3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
18
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
7
Breast Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
5
Neoplasm Metastasis
5
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Melanoma
1
Locally Advanced Pancreatic Cancer
1
Gastric Adenocarcinoma
1
Gallbladder Cancer Unresectable
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Brain Neoplasms
1
Anal Cancer Metastatic
1
Interventions
Cisplatin
12
Gemcitabine
9
Specimen Handling
6
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
Drug Therapy
5
toripalimab
4
Platinum
4
Nivolumab
4
Capecitabine
4
1,2-diaminocyclohexaneplatinum II citrate
4
spartalizumab
3
Radiotherapy
3
Immune Checkpoint Inhibitors
3
sintilimab
2
Ipilimumab
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
tislelizumab
1
relatlimab
1
pembrolizumab
1
olaparib
1
fluciclovine F-18
1
dehydroftorafur
1
cemiplimab
1
camrelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
130-nm albumin-bound paclitaxel
×
30 days
×
Clear all
No trials found.